Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

Katia Rea, Patrizia Pinciroli, Marialuisa Sensi, Federica Alciato, Brigitte Bisaro, Ludmila Lozneanu, Francesco Raspagliesi, Floriana Centritto, Sara Cabodi, Paola Defilippi, Gian Carlo Avanzi, Silvana Canevari, Antonella Tomassetti

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

High-grade epithelial ovarian cancer (HGEOC) is a clinically diverse and molecularly heterogeneous disease comprising subtypes with distinct biological features and outcomes. The receptor tyrosine kinases, expressed by EOC cells, and their ligands, present in the microenvironment, activate signaling pathways, which promote EOC cells dissemination. Herein, we established a molecular link between the presence of Gas6 ligand in the ascites of HGEOCs, the expression and activation of its receptor Axl in ovarian cancer cell lines and biopsies, and the progression of these tumors. We demonstrated that Gas6/Axl signalling converges on the integrin β3 pathway in the presence of the adaptor protein p130Cas, thus inducing tumor cell adhesion to the extracellular matrix and invasion. Accordingly, Axl and p130Cas were significantly co-expressed in HGEOC samples. Clinically, we identified an Axl-associated signature of 62 genes able to portray the HGEOCs with the shortest overall survival. These data biologically characterize a group of HGEOCs and could help guide a more effective therapeutic approach to be taken for these patients.

Original languageEnglish
Pages (from-to)30859-30875
Number of pages17
JournalOncotarget
Volume6
Issue number31
DOIs
Publication statusPublished - 2015

Fingerprint

Ovarian Neoplasms
Crk-Associated Substrate Protein
Ligands
Receptor Protein-Tyrosine Kinases
Ascites
Cell Adhesion
Integrins
Extracellular Matrix
Neoplasms
Biopsy
Cell Line
Survival
Genes
Ovarian epithelial cancer
Therapeutics

Keywords

  • Axl
  • Extracellular matrix
  • Gas6
  • Ovarian cancer
  • P130Cas

ASJC Scopus subject areas

  • Oncology

Cite this

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome. / Rea, Katia; Pinciroli, Patrizia; Sensi, Marialuisa; Alciato, Federica; Bisaro, Brigitte; Lozneanu, Ludmila; Raspagliesi, Francesco; Centritto, Floriana; Cabodi, Sara; Defilippi, Paola; Avanzi, Gian Carlo; Canevari, Silvana; Tomassetti, Antonella.

In: Oncotarget, Vol. 6, No. 31, 2015, p. 30859-30875.

Research output: Contribution to journalArticle

Rea, Katia ; Pinciroli, Patrizia ; Sensi, Marialuisa ; Alciato, Federica ; Bisaro, Brigitte ; Lozneanu, Ludmila ; Raspagliesi, Francesco ; Centritto, Floriana ; Cabodi, Sara ; Defilippi, Paola ; Avanzi, Gian Carlo ; Canevari, Silvana ; Tomassetti, Antonella. / Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome. In: Oncotarget. 2015 ; Vol. 6, No. 31. pp. 30859-30875.
@article{997f2f0a0349423c813d547459e42f80,
title = "Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome",
abstract = "High-grade epithelial ovarian cancer (HGEOC) is a clinically diverse and molecularly heterogeneous disease comprising subtypes with distinct biological features and outcomes. The receptor tyrosine kinases, expressed by EOC cells, and their ligands, present in the microenvironment, activate signaling pathways, which promote EOC cells dissemination. Herein, we established a molecular link between the presence of Gas6 ligand in the ascites of HGEOCs, the expression and activation of its receptor Axl in ovarian cancer cell lines and biopsies, and the progression of these tumors. We demonstrated that Gas6/Axl signalling converges on the integrin β3 pathway in the presence of the adaptor protein p130Cas, thus inducing tumor cell adhesion to the extracellular matrix and invasion. Accordingly, Axl and p130Cas were significantly co-expressed in HGEOC samples. Clinically, we identified an Axl-associated signature of 62 genes able to portray the HGEOCs with the shortest overall survival. These data biologically characterize a group of HGEOCs and could help guide a more effective therapeutic approach to be taken for these patients.",
keywords = "Axl, Extracellular matrix, Gas6, Ovarian cancer, P130Cas",
author = "Katia Rea and Patrizia Pinciroli and Marialuisa Sensi and Federica Alciato and Brigitte Bisaro and Ludmila Lozneanu and Francesco Raspagliesi and Floriana Centritto and Sara Cabodi and Paola Defilippi and Avanzi, {Gian Carlo} and Silvana Canevari and Antonella Tomassetti",
year = "2015",
doi = "10.18632/oncotarget.5087",
language = "English",
volume = "6",
pages = "30859--30875",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "31",

}

TY - JOUR

T1 - Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

AU - Rea, Katia

AU - Pinciroli, Patrizia

AU - Sensi, Marialuisa

AU - Alciato, Federica

AU - Bisaro, Brigitte

AU - Lozneanu, Ludmila

AU - Raspagliesi, Francesco

AU - Centritto, Floriana

AU - Cabodi, Sara

AU - Defilippi, Paola

AU - Avanzi, Gian Carlo

AU - Canevari, Silvana

AU - Tomassetti, Antonella

PY - 2015

Y1 - 2015

N2 - High-grade epithelial ovarian cancer (HGEOC) is a clinically diverse and molecularly heterogeneous disease comprising subtypes with distinct biological features and outcomes. The receptor tyrosine kinases, expressed by EOC cells, and their ligands, present in the microenvironment, activate signaling pathways, which promote EOC cells dissemination. Herein, we established a molecular link between the presence of Gas6 ligand in the ascites of HGEOCs, the expression and activation of its receptor Axl in ovarian cancer cell lines and biopsies, and the progression of these tumors. We demonstrated that Gas6/Axl signalling converges on the integrin β3 pathway in the presence of the adaptor protein p130Cas, thus inducing tumor cell adhesion to the extracellular matrix and invasion. Accordingly, Axl and p130Cas were significantly co-expressed in HGEOC samples. Clinically, we identified an Axl-associated signature of 62 genes able to portray the HGEOCs with the shortest overall survival. These data biologically characterize a group of HGEOCs and could help guide a more effective therapeutic approach to be taken for these patients.

AB - High-grade epithelial ovarian cancer (HGEOC) is a clinically diverse and molecularly heterogeneous disease comprising subtypes with distinct biological features and outcomes. The receptor tyrosine kinases, expressed by EOC cells, and their ligands, present in the microenvironment, activate signaling pathways, which promote EOC cells dissemination. Herein, we established a molecular link between the presence of Gas6 ligand in the ascites of HGEOCs, the expression and activation of its receptor Axl in ovarian cancer cell lines and biopsies, and the progression of these tumors. We demonstrated that Gas6/Axl signalling converges on the integrin β3 pathway in the presence of the adaptor protein p130Cas, thus inducing tumor cell adhesion to the extracellular matrix and invasion. Accordingly, Axl and p130Cas were significantly co-expressed in HGEOC samples. Clinically, we identified an Axl-associated signature of 62 genes able to portray the HGEOCs with the shortest overall survival. These data biologically characterize a group of HGEOCs and could help guide a more effective therapeutic approach to be taken for these patients.

KW - Axl

KW - Extracellular matrix

KW - Gas6

KW - Ovarian cancer

KW - P130Cas

UR - http://www.scopus.com/inward/record.url?scp=84945530687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945530687&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.5087

DO - 10.18632/oncotarget.5087

M3 - Article

AN - SCOPUS:84945530687

VL - 6

SP - 30859

EP - 30875

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 31

ER -